e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Cystic fibrosis: clinical problems and microbiology in adults
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
L. Clarke, K. Oates, C. Haworth, J. Elliott, A. Floto (Cambridge, United Kingdom)
Source:
Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Session:
Cystic fibrosis: clinical problems and microbiology in adults
Session type:
Thematic Poster Session
Number:
1169
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Clarke, K. Oates, C. Haworth, J. Elliott, A. Floto (Cambridge, United Kingdom). Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model. Eur Respir J 2013; 42: Suppl. 57, 1169
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Cystic fibrosis and arthritis in children
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Two-compartment model of gas mixing in patients with asthma and cystic fibrosis
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Endothelial dysfunction in children and young adults with cystic fibrosis – A combined diagnostic approach of plethysmographic and biochemical markers: New applications
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
The CF-ABLE score: A 2-year evaluation of a 4-year prognostic tool
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
How useful is the lung ultrasound in cystic fibrosis?
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
A new risk factor predicts ABPA in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019
Year: 2020
Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021
Evaluation of disease knowledge in children with cystic fibrosis and their families
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept